Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia
|
Feb 2017
|
JAMA Oncol
|
|
Highlights in Hematologic Malignancy Treatments: Leukemia, Myelodysplastic Syndromes, and Allotransplant-New Drugs on the Horizon for Acute Myeloid Leukemia
|
Oct 2016
|
JAMA Oncol
|
myelodysplastic syndromes (MDS)
|
Young Enough to Undergo Allogeneic Transplantation for Myelodysplastic Syndromes?: Considering the Results of the Medicare Coverage With Evidence Development Study
|
Dec 2019
|
JAMA Oncology
|
myelodysplastic syndromes (MDS)
|
Genomic Biomarkers to Predict Resistance to Hypomethylating Agents in Patients With Myelodysplastic Syndromes Using Artificial Intelligence
|
Sep 2019
|
JCO Precision Oncology
|
myelodysplastic syndromes (MDS)
|
Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplantat
|
Feb 2021
|
Journal for immunotherapy of cancer
|
myelodysplastic syndromes (MDS)
|
Paroxysmal Nocturnal Hemoglobinuria: Current Management, Unmet Needs, and Recommendations
|
Dec 2023
|
Journal of Blood Medicine
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS)
|
Oct 2023
|
Journal of Clinical Oncology
|
myelodysplastic syndromes (MDS)
|
Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase-II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS)
|
Jun 2023
|
Journal of Clinical Oncology
|
myelodysplastic syndromes (MDS)
|
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
|
May 2023
|
Journal of Clinical Oncology
|
myelodysplastic syndromes (MDS)
|
Eprenetapopt Plus Azacitidine in TP53-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM)
|
Feb 2021
|
Journal of clinical oncology: official journal of the American Society Clinical Oncology
|
myelodysplastic syndromes (MDS)
|